Endo Health (ENDP), Allergan (AGN), AMS Enter BOTOX Delivery Via JetTouch Collaboration
Tweet Send to a FriendGet Alerts ENDP Hot Sheet
Up)
Trade ENDP Now!
American Medical Systems (AMS), an Endo Health Solutions company (Nasdaq: ENDP), announced today it has signed a co-development agreement with Allergan, Inc. (NYSE: AGN) to jointly develop and seek regulatory approval for the delivery of BOTOX (onabotulinumtoxinA) using the JetTouch system for treatment of overactive bladder (OAB).
AMS' JetTouch is a novel injection platform that has the potential to enable needle-free injection into any area of the body reachable by endoscopic or percutaneous access. Needle-free injection with the JetTouch system is being evaluated as an innovative means for local drug delivery and may provide treatment administration efficiencies for the physician.
Under the co-development agreement, AMS will first develop JetTouch for general use in the bladder. Subject to the FDA approval of BOTOX for injection by needle as a treatment for OAB, AMS, in collaboration with Allergan, will seek to add BOTOX to the JetTouch label, and Allergan plans to seek regulatory advice to add the delivery of BOTOX with JetTouch to the BOTOX label.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
AMS' JetTouch is a novel injection platform that has the potential to enable needle-free injection into any area of the body reachable by endoscopic or percutaneous access. Needle-free injection with the JetTouch system is being evaluated as an innovative means for local drug delivery and may provide treatment administration efficiencies for the physician.
Under the co-development agreement, AMS will first develop JetTouch for general use in the bladder. Subject to the FDA approval of BOTOX for injection by needle as a treatment for OAB, AMS, in collaboration with Allergan, will seek to add BOTOX to the JetTouch label, and Allergan plans to seek regulatory advice to add the delivery of BOTOX with JetTouch to the BOTOX label.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Merck (MRK) Says Efficacy Not Achieved in Preladenant Phase 3s; Will Discontinue
- Sprint (S), SoftBank Receive Final State Regulatory Approval in Proposed Deal
- Universal Insurance (UVE) Completes 6.67M in Buybacks
Create E-mail Alert Related Categories
Corporate News, FDA
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
